Clin Infect Dis

1. MWESIGWA B, Sawe F, Oyieko J, Mwakisisile J, et al
   Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
   Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093.
   

   >> Share

   
   

   
   Clin Microbiol Rev

2. MIURA K, Flores-Garcia Y, Long CA, Zavala F, et al
   Vaccines and monoclonal antibodies: new tools for malaria control.
   Clin Microbiol Rev. 2024 Apr 24:e0007123. doi: 10.1128/cmr.00071.
   

   >> Share

   
   

   
   J Gen Virol

3. ZHANG J, Cui L, Zhang Y, Pan H, et al
   Oral administration of PEDV-dissolved Alg-CS gel induces high and sustained mucosal immunity in mice.
   J Gen Virol. 2024;105.
   

   >> Share

   
   

   
   J Infect Dis

4. ORUMAA M, Lahlum EJ, Gulla M, Tota J, et al
   Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: A registry-based study of 0,9 million Norwegian women.
   J Infect Dis. 2024 Apr 25:jiae209. doi: 10.1093.
   

   >> Share

   
   

   
   J Virol

5. THORESEN D, Matsuda K, Urakami A, Ngwe Tun MM, et al
   A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates.
   J Virol. 2024 Apr 22:e0023924. doi: 10.1128/jvi.00239.
   

   >> Share

   
   

   
   JAMA

6. ALLEN MR, Desai N, Namazi A, Leas E, et al
   Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
   JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
   

   >> Share

   
   
7. HARRIS E
   COVID-19 Infection Tied to Slight Cognitive Deficits.
   JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
   

   >> Share

   
   

   
   Minerva Pediatr (Torino)

8. LEE S, Erdem G, Yasuhara J
   Multisystem inflammatory syndrome in children associated with COVID-19: from pathophysiology to clinical management and outcomes.
   Minerva Pediatr (Torino). 2024;76:268-280.
   

   >> Share

   
   

   
   MMWR Morb Mortal Wkly Rep

9. KALLAY R, Doshi RH, Muhoza P, Choi MJ, et al
   Use of Ebola Vaccines - Worldwide, 2021-2023.
   MMWR Morb Mortal Wkly Rep. 2024;73:360-364.
   

   >> Share

   
   
10. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

11. LIN W, Wang B, Wang M, Wang Y, et al
    The Unneglectable Disease Burden of Otitis Media Among Children in China: A Systematic Review and Meta-analysis.
    Pediatr Infect Dis J. 2024;43:403-409.
    

    >> Share

    
    

    
    Pediatrics

12. SAPER JK, Heffernan M, Simon NE, Davis MM, et al
    RSV Vaccination Intention Among People Who Are or Plan to Become Pregnant.
    Pediatrics. 2024 Apr 25:e2023065140. doi: 10.1542/peds.2023-065140.
    

    >> Share

    
    

    
    PLoS One

13. RAZAFINDRAKOTO M, Roubaud F, Castilho MR, Pero V, et al
    Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.
    PLoS One. 2024;19:e0288894.
    

    >> Share

    
    
14. KASSA ZY, Scarf V, Turkmani S, Fox D, et al
    Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study.
    PLoS One. 2024;19:e0301994.
    

    >> Share

    
    
15. KHAMI MR, Karimi M, Folayan MO, Shamshiri AR, et al
    Patients' knowledge about dental emergencies, COVID-19 transmission, and required preparations in dental settings.
    PLoS One. 2024;19:e0301460.
    

    >> Share

    
    
16. FANG F, Clemens JD, Zhang ZF, Brewer TF, et al
    Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    PLoS One. 2024;19:e0301830.
    

    >> Share

    
    
17. COGILL S, Nallamshetty S, Fullenkamp N, Heberer K, et al
    Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.
    PLoS One. 2024;19:e0290221.
    

    >> Share

    
    

    
    Science

18. STREICKER DG, Griffiths ME, Antia R, Bergner L, et al
    Developing transmissible vaccines for animal infections.
    Science. 2024;384:275-277.
    

    >> Share

    
    

    
    Vaccine

19. MUSA S, Merdrignac L, Skocibusic S, Nedic R, et al
    BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study.
    Vaccine. 2024 Apr 20:S0264-410X(24)00471-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
20. LIEVRE G, Sicsic J, Galmiche S, Charmet T, et al
    Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France.
    Vaccine. 2024 Apr 19:S0264-410X(24)00438-9. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
21. LV M, Du J, Xie MZ, Zhou Y, et al
    Protective effect of PCV13 against all-cause hospitalized pneumonia in children in Beijing, China: real-world evidence.
    Vaccine. 2024;42:3091-3098.
    

    >> Share

    
    
22. WANG Z, Wang M, Wang F, Luo Y, et al
    Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurella multocida serogroups in mouse models.
    Vaccine. 2024;42:3075-3083.
    

    >> Share

    
    
23. MAGALI P, Sophie M, Arnaud B, Pol L, et al
    Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings.
    Vaccine. 2024;42:3018-3023.
    

    >> Share

    
    
24. GRANT LR, Hanquet G, Sepulveda-Pachon IT, Theilacker C, et al
    Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance.
    Vaccine. 2024;42:2983-2993.
    

    >> Share

    
    
25. SONG S, Madewell ZJ, Liu M, Miao Y, et al
    A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants.
    Vaccine. 2024 Apr 22:S0264-410X(24)00476-6. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
26. SWITALSKI J, Miazga W, Wnuk K, Tatara T, et al
    Analyzing the dynamics of meningococcal vaccinations initiatives by local government units in Poland (2017-2021) - Scope, challenges and recommendations.
    Vaccine. 2024 Apr 22:S0264-410X(24)00472-9. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
27. SELLIES AJ, Knol MJ, de Melker HE, Bruijning-Verhagen PCJL, et al
    Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections.
    Vaccine. 2024 Apr 23:S0264-410X(24)00468-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
28. FUJITA DM, da Silva Nali LH, da Costa RR, de Andrade Junior HF, et al
    Low vaccine coverage and varicella outbreaks in Brazil - 2019-2022.
    Vaccine. 2024 Apr 24:S0264-410X(24)00435-3. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    

    
    Virus Res

29. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share